178 related articles for article (PubMed ID: 16917759)
1. The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.
Talmud PJ; Cooper JA; Hattori H; Miller IP; Miller GJ; Humphries SE
Diabetologia; 2006 Oct; 49(10):2337-40. PubMed ID: 16917759
[TBL] [Abstract][Full Text] [Related]
2. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.
Dallinga-Thie GM; van Tol A; Hattori H; van Vark-van der Zee LC; Jansen H; Sijbrands EJ;
Diabetologia; 2006 Jul; 49(7):1505-11. PubMed ID: 16752169
[TBL] [Abstract][Full Text] [Related]
3. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
4. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
[TBL] [Abstract][Full Text] [Related]
5. The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes.
Dorfmeister B; Cooper JA; Stephens JW; Ireland H; Hurel SJ; Humphries SE; Talmud PJ
Biochim Biophys Acta; 2007 Mar; 1772(3):355-63. PubMed ID: 17197160
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.
Chandak GR; Ward KJ; Yajnik CS; Pandit AN; Bavdekar A; Joglekar CV; Fall CH; Mohankrishna P; Wilkin TJ; Metcalf BS; Weedon MN; Frayling TM; Hattersley AT
BMC Med Genet; 2006 Oct; 7():76. PubMed ID: 17032446
[TBL] [Abstract][Full Text] [Related]
7. Consumption of whole grains and legumes modulates the genetic effect of the APOA5 -1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes.
Kang R; Kim M; Chae JS; Lee SH; Lee JH
Trials; 2014 Apr; 15():100. PubMed ID: 24690159
[TBL] [Abstract][Full Text] [Related]
8. The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes.
Cabré A; Lázaro I; Girona J; Manzanares JM; Marimón F; Plana N; Guardiola M; Heras M; Masana L
Nutr Metab Cardiovasc Dis; 2010 May; 20(4):243-8. PubMed ID: 19765959
[TBL] [Abstract][Full Text] [Related]
9. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
[TBL] [Abstract][Full Text] [Related]
10. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.
Talmud PJ; Hawe E; Martin S; Olivier M; Miller GJ; Rubin EM; Pennacchio LA; Humphries SE
Hum Mol Genet; 2002 Nov; 11(24):3039-46. PubMed ID: 12417525
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
[TBL] [Abstract][Full Text] [Related]
13. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
[TBL] [Abstract][Full Text] [Related]
14. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
Qi L; Liu S; Rifai N; Hunter D; Hu FB
Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
[TBL] [Abstract][Full Text] [Related]
15. Contribution of APOA5-1131C allele to the increased susceptibility of diabetes mellitus in association with higher triglyceride in Korean women.
Lee KH; Kim OY; Lim HH; Lee YJ; Jang Y; Lee JH
Metabolism; 2010 Nov; 59(11):1583-90. PubMed ID: 20303129
[TBL] [Abstract][Full Text] [Related]
16. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
Henneman P; Schaap FG; Havekes LM; Rensen PC; Frants RR; van Tol A; Hattori H; Smelt AH; van Dijk KW
Atherosclerosis; 2007 Jul; 193(1):129-34. PubMed ID: 16777114
[TBL] [Abstract][Full Text] [Related]
17. Association of APOA5 -1131T>C polymorphism and serum lipid levels in patients with type 2 diabetes.
Celap I; Simundic AM; Nikolac N; Kackov S; Katalinic D
DNA Cell Biol; 2013 Oct; 32(10):589-93. PubMed ID: 23919616
[TBL] [Abstract][Full Text] [Related]
18. [Association of apolipoprotein A5 gene -1131T/C polymorphism with lipid metabolism and insulin resistance in patients with type II diabetes mellitus].
Zhai GH; Wen P; Guo LF; Chen L
Yi Chuan; 2007 May; 29(5):541-6. PubMed ID: 17548321
[TBL] [Abstract][Full Text] [Related]
19. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein A5 gene polymorphism -1131T-->C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese.
Yan SK; Cheng XQ; Song YH; Xiao XH; Bi N; Chen BS
Clin Chem Lab Med; 2005; 43(6):607-12. PubMed ID: 16006256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
